Sharon Kedar is Co-Founder, Partner of Northpond Ventures, a leading science, medical, and technology-driven venture capital firm. Kedar is currently a board director at 908 Devices, Emulate, Isoplexis, Ultivue, and Vizgen. She was previously CFO of Sands Capital Management. Over her 15 years with Sands Capital, assets under management grew from $1.5 billion to $50 billion.
Prior to Sands Capital, Kedar was a consultant at McKinsey & Company. Kedar has an MBA from Harvard Business School and a BA in Economics from Rice University. She is a CFA charterholder. Kedar is an advocate for financial literacy, and has co-authored two books on personal finance for women. Her work has been featured nationally.